They are also concerned that, if there are any yet unknown, long-term negative consequences from the drugs, they dont want their brands directly associated with the medications
We consider that 80 nM of GLP-1 is comparable to the effective serum concentration of dulaglutide used in our case (Fig
[8] Bommer, C., Sagalova, V., Heesemann, E., Manne-Goehler, J., Atun, R., Brnighausen, T.,
But theyre the only assets in the listed Indian pharma universe that could turn GLP-1 from a defensive franchise into an offensive one
These include a history of pancreatitis, severe gastrointestinal conditions such as gastroparesis, gallbladder disease, and reduced kidney function, where dehydration from vomiting or diarrhea is the main concern
Communication with your healthcare team is essential for long-term success